Axitinib is a tyrosine kinase inhibitor used to treat advanced renal cell carcinoma. It inhibits vascular endothelial growth factor receptors (VEGFR), blocking angiogenesis and tumor growth. It is administered orally and monitored for hypertension, a common side effect. It is often used after failure of prior systemic therapy.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Axitinib and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Axitinib impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Axitinib-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
